求助7篇文献 不胜感激

aaaszw

0 U0 K0 J+ B) t' J% @& n
. q! M% I# F3 d4 X, c
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade., q8 M; q. L! u' [
https://www.ncbi.nlm.nih.gov/pubmed/279120617 l/ q7 B2 s) G) P

* s) U- o( \1 m5 f; r4 C9 j* CThe long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan.
; Y# D8 M0 L& j5 W  _6 Q) ?https://www.ncbi.nlm.nih.gov/pubmed/27525555' ~" O6 \, a2 _  P) D
8 T4 k0 T; C/ {2 g
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8(+) T Cell Exhaustion3 e6 |8 l  o6 |  E% w' S
https://www.ncbi.nlm.nih.gov/pubmed/27496729
9 e5 l3 e1 n" ^1 v: k) v! z/ k
. o5 x. b' c7 ^, }7 yCutting Edge: B Cell-Intrinsic T-bet Expression Is Required To Control Chronic Viral Infection.4 O# p" L* f* z# f6 L( D2 J1 L
https://www.ncbi.nlm.nih.gov/pubmed/27430722
% `: w% H2 E7 z' m
: O9 v$ K2 a3 I9 {6 SCostimulatory and Coinhibitory Receptor Pathways in Infectious Disease.
. e" W, E* Z* b( d+ J% s9 J& k  Fhttps://www.ncbi.nlm.nih.gov/pubmed/27192569
9 z( v' A& r. S* s" Z0 @
$ n+ f- q# }, KCombination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling
2 x' ^2 e- P  o7 E7 F# ehttps://www.ncbi.nlm.nih.gov/pubmed/27058661
6 B8 k1 [/ z7 L) Q7 \2 [0 l+ v9 W  l8 G% O1 i
De-Risking Immunotherapy: Report of a Consensus Workshop of the Cancer Immunotherapy Consortium of the Cancer Research Institute6 @# h5 U3 b% b# G
https://www.ncbi.nlm.nih.gov/pubmed/27036972

lchanlon

回复 aaaszw 的帖子) w$ {: a- U; }

0 U9 \9 k8 X8 S* UHere you go ! h; E, J  P& @% ~4 k% W. A+ I
: E8 k3 u+ b+ i, i, u4 f
Good luck!

lchanlon

回复 aaaszw 的帖子/ Y6 d4 g0 U! \9 f
& ]0 G9 g* h/ a! _* P
Here you go % ?5 X# v  V. s2 v7 N$ U

# J, A0 P, d) E, O% X: KGood luck!

aaaszw

回复 lchanlon 的帖子7 B" `! V( \( g! P$ U3 i6 h) B

6 `5 q4 Y3 P+ @, c; f9 gmerci beaucoup ：）